ACADIA Q1 2026 slides: revenue rises 11% despite earnings miss

Introduction & Market Context ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) presented its first quarter 2026 financial results on May 6, 2026, revealing a complex picture of commercial momentum offset by near-term profitability challenges. While the company delivered 11% year-over-year revenue growth to $268.1 million, earnings per share of $0.02 fell significantly short of the $0.05 analyst forecast,…

Read More

Nigeria: Manufacturing Sector's Tax Contribution Rises to N1.17trn, Spurs Demand for Fiscal Support

The manufacturing sector’s contribution to tax revenue collections in Nigeria maintained an upward trend in 2025, contributing a total of N1.17 trillion in Value Added Tax (VAT), an increase of 45.61 per cent over the N803.53 billion in 2024. The sector’s Company Income Tax (CIT) contribution rose to N881.29 billion, marking a 32.83 per cent…

Read More